 | |||||||
| lose weight | |||||||
| NEWS | |||||||
| How a New Weight-Loss Pill Could Transform Health | TIME The first truly revolutionary oral drug for obesity, made by Eli Lilly, may soon be on the way.
| |||||||
| Lilly pill helps diabetes patients lose weight by nearly 8%, shares surge | Reuters Eli Lilly's experimental pill led to weight loss of nearly 8% at the highest dose and lowered blood sugar in patients with type 2 diabetes in a ...
| |||||||
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients - CNBC The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes ...
| |||||||
| Eli Lilly says experimental GLP-1 pill helped people with diabetes lose weight and lower blood sugar The participants were still losing weight by the end of the 40-week trial. The trial also achieved its primary goal of lowering participants' A1C ...
| |||||||
Lilly says daily pill can lower blood sugar and weight in people with Type 2 diabetes The drugmaker said that in a phase 3 clinical trial, the experimental drug orforglipron reduced A1C levels and led to weight loss of up to 16 ...
| |||||||
| New daily weight-loss pill shows success at clinical trial | Obesity | The Guardian A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, ...
| |||||||
| Lilly's First Pill for Diabetes, Weight Loss Shows Positive Study Results - WSJ The first GLP-1 weight-loss pill is a step closer to hitting the market. Eli Lilly said its experimental pill met its goals in a pivotal study, ...
| |||||||
| Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
| |||||||
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight ...
| |||||||
| Daily pill from Eli Lilly helps patients control blood sugar, lose weight, Phase 3 study shows Companies have been trying to develop pills that could offer the weight loss benefits that the currently available injectable drugs do.
| |||||||
| See more results | Edit this alert | |||||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
